SharePost Content Read More Yahoo Finance #finance Post navigation How QIAGEN’s (QGEN) Diagnostics Expansion Strengthens Its Takeover Appeal Why Revolution Medicines (RVMD) Still Looks Like a Prime Takeover Target After Daraxonrasib Data